Topiramate
Product Images NDC 45865-551

4 FDA label images from Medsource Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 45865-551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (551)

Pdp (551)
Topiramate Tablets 25 mg packaging label by Sun Pharma, labeled as generic for Topamax. The package contains 90 tablets. The label includes directions to take tablets without drowsiness or alcohol and specifies the tablets are white and round. The product NDC is 45865-0551-90.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of topiramate showing its molecular framework with multiple oxygen atoms, methyl groups, and a sulfonamide functional group. The diagram depicts the specific arrangement of atoms and bonds in the active ingredient topiramate.*
FDA Label Image

Figure-1jpg (Figure 1)

Figure-1jpg (Figure 1)
A Kaplan-Meier curve showing cumulative rates over time to first seizure for Topiramate at two dosages: 50 mg/day and 400 mg/day. The X-axis is time in days up to 500, and the Y-axis represents cumulative rates for time to first seizure from 0 to 0.5. The graph includes lines for groups of patients taking 50 mg/day (N=234) and 400 mg/day (N=236). A p-value of 0.0002 is noted on the chart.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A bar chart showing change from baseline to double-blind phase in average monthly migraine period rate for Placebo and Topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day. The chart compares results from two studies (Study 10 and Study 11) using bars for each group. Statistical significance is indicated for Topiramate 100 mg/day and 200 mg/day doses with asterisks representing p-values of <0.010 and <0.001.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.